Sensitivity analysis using biomarker status defined only via troponin
| Cangrelor (N=2654) | Placebo (N=2641) | OR (95% CI) | p Value | |
|---|---|---|---|---|
| Type 4a MI (3×ULN) (N=116) | 40 (1.6) | 58 (2.2) | 0.68 (0.45 to 1.02) | 0.063 |
| Total MI (N=144) | 51 (1.9) | 77 (2.9) | 0.65 (0.46 to 0.93) | 0.019 |
| Primary endpoint* (N=187) | 67 (2.5) | 105 (4.0) | 0.63 (0.46 to 0.85) | 0.003 |
Data presented as no. (%).
*Primary endpoint includes MI, death or ischaemia driven revascularisation.
EP, endpoint; MI, myocardial infarction; ULN, upper limit of normal.